Candesartan Stada 16 mg, Tabletten - 28 Swissmedic Key 66096021 Registration Holder Spirig HealthCare AG Name Candesartan Stada 16 mg, Tabletten Date of registration 04.08.2016 Introduction of Sequence 04.08.2016 ATC-Classification Candesartan (C09CA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.10. Show package size 28 Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Deductible k.A. Feedback FB GTIN 7680660960215 Medication Code Synthetika Pharmacode Disponibility
Composition candesartanum cilexetilum 16 mg, maydis amylum, lactosum monohydricum 121.80 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.4 mg, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 16 mg
BAG: Active Agent Dose Candesartanum Cilexetilum 16 mg
Inactive agents Dose Carmellosum Natricum Conexum Hydroxypropylcellulosum Lactose Monohydrate 121.8 mg Magnesii Stearas Maydis Amylum Pro Compresso Triethylis Citras
Source Data was imported : 04.02.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
